Federated Hermes Inc. Sells 5,453 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Federated Hermes Inc. decreased its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 35.0% in the 2nd quarter, Holdings Channel.com reports. The firm owned 10,140 shares of the company’s stock after selling 5,453 shares during the period. Federated Hermes Inc.’s holdings in Prestige Consumer Healthcare were worth $698,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. GHP Investment Advisors Inc. raised its position in shares of Prestige Consumer Healthcare by 1.1% in the second quarter. GHP Investment Advisors Inc. now owns 86,540 shares of the company’s stock valued at $5,958,000 after buying an additional 928 shares in the last quarter. BOKF NA increased its stake in Prestige Consumer Healthcare by 120.9% during the 2nd quarter. BOKF NA now owns 7,584 shares of the company’s stock worth $522,000 after acquiring an additional 4,150 shares during the period. Choreo LLC acquired a new position in Prestige Consumer Healthcare in the 2nd quarter valued at $677,000. Quest Partners LLC lifted its position in shares of Prestige Consumer Healthcare by 2,826.7% during the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after acquiring an additional 424 shares during the period. Finally, Norden Group LLC grew its holdings in shares of Prestige Consumer Healthcare by 25.9% during the 2nd quarter. Norden Group LLC now owns 12,435 shares of the company’s stock worth $856,000 after purchasing an additional 2,559 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Down 1.2 %

NYSE PBH opened at $73.03 on Monday. The business has a fifty day moving average price of $71.22 and a two-hundred day moving average price of $69.65. The stock has a market capitalization of $3.63 billion, a PE ratio of 17.51, a PEG ratio of 2.08 and a beta of 0.48. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.34 and a fifty-two week high of $75.80. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.04. The business had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. Prestige Consumer Healthcare’s revenue for the quarter was down 4.4% on a year-over-year basis. During the same period in the prior year, the company earned $1.06 EPS. Equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, DA Davidson raised their price target on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $98.75.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.